TGFB1 and breast cancer: In a breast cancer context, the accumulation of Wnt molecules due to the TGF-β pathway, combined with the lack of SFRP1, result in a dramatic over-activation of the Wnt signaling pathway and, consequently, in an increasing cell proliferation (Figure 2B).